查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842404

美国人工器官和仿生学市场：市场规模、份额、趋势分析（按产品和技术划分）、细分市场预测（2025-2033 年）

U.S. Artificial Organs And Bionics Market Size, Share & Trends Analysis Report By Product (Artificial Organs, Bionic), By Technology (Mechanical, Electronic) And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 60 Pages | 商品交期: 2-10个工作天内

价格

美国人工器官和仿生市场概览

据估计，美国人造器官和仿生学市场在 2024 年的价值为 153.5 亿美元，预计到 2033 年将达到 301.1 亿美元，2025 年至 2033 年的复合年增长率为 7.7%。

市场成长的驱动因素是器官移植数量的增加和等待捐赠器官人数的增加。

根据美国人力资源与服务管理局的报告，2023年美国全国器官移植等待名单上的人数超过10.4万人。目前，平均每10分钟就有一人被列入等待名单，这凸显了为满足这一未被满足的需求而日益增长的人工医疗设备需求。这些设备涵盖了旨在恢復器官功能或完全取代衰竭器官的各种装置。美国国立卫生研究院（NIH）下属的国家医疗图像与生物工程研究所（NIBIB）积极支持这些技术的研发，以帮助人们过着更健康、更独立的生活。

美国政府透过大量的研究经费，在促进美国人工器官和仿生产业创新方面发挥关键作用。美国国立卫生研究院（NIH）透过包括国家神经病变与中风研究所（NINDS）在内的多个机构，资助下一代义肢的研究，这些假体可以透过电脑介面恢復患者的运动和感觉功能。

美国人工器官与仿生市场细分

该报告预测了2021年至2033年各国的收入成长情况，并分析了各细分市场的最新产业趋势。报告按产品和技术对美国的人工器官和仿生学市场进行了细分：

  • 按产品分類的展望：收入（十亿美元，2021-2033 年）
  • 人工器官
    • 肾
    • 心
    • 肝
    • 肺
    • 胰臟
  • 仿生学
    • 人工电子耳
    • 外骨骼
    • 仿生边缘
    • 脑仿生学
    • 视觉仿生学
  • 技术展望：收入（十亿美元，2021-2033 年）
  • 机械的
  • 电子的

目录

第一章 分析方法和范围

第二章执行摘要

第三章美国人工器官与仿生市场：驱动因素、趋势与范围

  • 市场关联性展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国人工器官与仿生学市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
    • 美国人工器官与仿生学市场：产品线分析

第四章：美国人工器官与仿生产品市场：估算与趋势分析

  • 产品仪錶板
  • 美国人工器官与仿生产品市场：变化分析
  • 美国人工器官及仿生产品市场规模及趋势分析（2021-2033）
  • 人工器官
  • 仿生学

第五章美国人工器官与仿生市场：依技术分類的估算与趋势分析

  • 技术仪錶板
  • 美国人工器官与仿生市场：依技术分類的变化分析
  • 美国人工器官及仿生技术市场规模及趋势分析（2021-2033）
  • 机械的
  • 电子的

第六章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要企业热力图分析（2024 年）
  • 公司简介
    • ABIOMED
    • Berlin Heart
    • SynCardia Systems, LLC
    • BiVACOR Inc.
    • Cochlear Ltd.
    • Ekso Bionics
    • Edwards Lifesciences Corporation
    • Boston Scientific Corporation
    • Jarvik Heart, Inc
    • Medtronic
Product Code: GVR-4-68040-758-2

U.S. Artificial Organs And Bionics Market Summary

The U.S. artificial organs and bionics market size was estimated at USD 15.35 billion in 2024 and is projected to reach USD 30.11 billion by 2033, growing at a CAGR of 7.7% from 2025 to 2033. The market growth is attributed to the increasing number of transplants and the rising number of people waiting for donors.

In 2023, as reported by the Human Resource and Services Administration, the national transplant waiting list in the U.S. exceeded 104,000 individuals. Currently, a new name is placed on the waiting list every ten minutes, underscoring the increasing need for artificial medical devices to address unmet demand. This includes various devices designed to restore function or fully replace failed organs. The National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health (NIH), actively supports the development of these technologies to help people live healthier, more independent lives.

The U.S. government plays a key role in fostering innovation in the U.S. artificial organs and bionic industry through significant funding for research. The NIH, through its various institutes such as the National Institute of Neurological Disorders and Stroke (NINDS), has funded research into next-generation neural prosthetics that can restore movement and sensation by using a computerized interface.

U.S. Artificial Organs And Bionic Market Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artificial organs and bionic market report based on product and technology:

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Artificial Organs
    • Kidney
    • Heart
    • Liver
    • Lungs
    • Pancreas
  • Bionic
    • Cochlear Implant
    • Exoskeleton
    • Bionic Limbs
    • Brain Bionic
    • Vision Bionic
  • Technology Outlook (Revenue, USD Billion, 2021 - 2033)
  • Mechanical
  • Electronic

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Technology
  • 2.3. Competitive Insights

Chapter 3. U.S. Artificial Organs and Bionic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Artificial Organs and Bionic Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. U.S. Artificial Organs and Bionic Market: Pipeline Analysis

Chapter 4. U.S. Artificial Organs and Bionic Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Artificial Organs and Bionic Market: Product Movement Analysis
  • 4.3. U.S. Artificial Organs and Bionic Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
  • 4.4. Artificial Organs
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.1. Kidney
        • 4.4.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.2. Heart
        • 4.4.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.3. Liver
        • 4.4.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.4. Lungs
        • 4.4.1.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.5. Pancreas
        • 4.4.1.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.5. Bionics
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.1. Cochlear Implant
        • 4.5.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.2. Exoskeleton
        • 4.5.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.3. Bionic Limbs
        • 4.5.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.4. Brain Bionic
        • 4.5.1.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.5. Vision Bionic
        • 4.5.1.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 5. U.S. Artificial Organs and Bionic Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. U.S. Artificial Organs and Bionic Market: Technology Movement Analysis
  • 5.3. U.S. Artificial Organs and Bionic Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Billion)
  • 5.4. Mechanical
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 5.5. Electronic
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company heat map analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. ABIOMED
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Berlin Heart
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. SynCardia Systems, LLC
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. BiVACOR Inc.
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Cochlear Ltd.
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Ekso Bionics
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Edwards Lifesciences Corporation
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Boston Scientific Corporation
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Jarvik Heart, Inc
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Medtronic
      • 6.4.10.1. Company overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. Artificial Organs and Bionic Market, 2021 - 2033 (USD Billion)
  • Table 3 U.S. Artificial Organs and Bionic Market, by Product, 2021 - 2033 (USD Billion)
  • Table 4 U.S. Artificial Organs and Bionic Market, by Technology, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Information Procurement
  • Fig. 7 Market Formulation and Validation
  • Fig. 8 Data Validating & Publishing
  • Fig. 9 Market Segmentation & Scope
  • Fig. 10 U.S. Artificial Organs and Bionic Market Snapshot
  • Fig. 11 Product Segment Snapshot
  • Fig. 12 Technology Segment Snapshot
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 U.S. Artificial Organs and Bionic Market Value, 2024 (USD Billion)
  • Fig. 16 U.S. Artificial Organs and Bionic Market - Value Chain Analysis
  • Fig. 17 U.S. Artificial Organs and Bionic Market - Market Dynamics
  • Fig. 18 U.S. Artificial Organs and Bionic Market - PORTER's Analysis
  • Fig. 19 U.S. Artificial Organs and Bionic Market - PESTEL Analysis
  • Fig. 20 U.S. Artificial Organs and Bionic Market Estimates & Forecasts, By Product: Key Takeaways
  • Fig. 21 U.S. Artificial Organs and Bionic Market Share, By Product, 2024 & 2033
  • Fig. 22 Artificial organ Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 23 Kidney Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 24 Heart Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 25 Liver Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 26 Lungs Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 27 Pancreas Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 28 Bionics Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 29 Cochlear Implant Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 30 Exoskeleton Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 31 Bionic Limbs Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 32 Brain Bionic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 33 Vision Bionic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 34 U.S. Artificial Organs and Bionic Market Estimates & Forecasts, By Technology: Key Takeaways
  • Fig. 35 U.S. Artificial Organs and Bionic Market Share, By Technology, 2024 & 2033
  • Fig. 36 Mechanical Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 37 Electronic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 38 Key Company Categorization
  • Fig. 39 Company Market Positioning
  • Fig. 40 Strategy Mapping